Latest filing published 03 Oct 2017 for Ernexa Therapeutics Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -27.6%Entry US$195,000.00 · Close at T+365 US$141,150.00
- -16.8%Entry US$180,000.00 · Close at T+365 US$149,700.00
- -46.4%Entry US$210,000.00 · Close at T+365 US$112,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steve Mitgang: trading record in brief
Steve Mitgang is a declared insider of Ernexa Therapeutics Inc., with filings sourced from SEC (Form 4). Between 15 May 2015 and 29 September 2017, the trades on record add up to 6 filings.
On the market, this insider has only ever bought: 4 purchases, €9,641 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants.
A typical purchase (the median) is worth €1,878. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +26.1%. These figures describe past trades and do not predict future prices.
The newest entry dates from 3 October 2017: a share grant, in Ernexa Therapeutics Inc. The last insider purchase was made public on 24 June 2015, 4,156 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Steve Mitgang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 816 shares0Common StockSEC:0001493152-17-011200:0
- 697 shares0Common StockSEC:0001493152-17-007509:0
- 15,000 shares@ US$0.42Common StockSEC:0001019687-15-002507:0Canonical exit: 13 Aug 2015 (T+90)
- 1,600 shares@ US$0.2562Common StockSEC:0001019687-15-002462:0Canonical exit: 17 Sept 2015 (T+90)
- 8,400 shares@ US$0.2592Common StockSEC:0001019687-15-002462:1Canonical exit: 17 Sept 2015 (T+90)
- 5,000 shares@ US$0.42Common StockSEC:0001019687-15-002248:0Canonical exit: 13 Aug 2015 (T+90)
6 of 6 declarations
